AI Article Synopsis
- Surfactant protein D (SP-D) levels in serum can indicate prognosis for patients with idiopathic pulmonary fibrosis (IPF), with higher levels linked to worse outcomes.
- The study involved 82 IPF patients and an experimental model using rats to analyze the protein and mRNA levels of SP-A and SP-D.
- While SP-D was associated with poor prognoses, SP-A did not significantly impact survival; the rise in these markers was linked to lung inflammation (alveolitis) rather than fibrosis.
Article Abstract
Objectives: Surfactant protein (SP) A and D are specific serum markers for interstitial lung diseases including idiopathic pulmonary fibrosis (IPF). The authors evaluated the critical roles of these markers on the prognoses of patients with IPF and the mechanisms of their elevation in sera.
Methodology: The authors evaluated the relationship between prognosis and the serum markers in 82 IPF patients. The protein content and mRNA expression of the markers were evaluated using rats with interstitial pneumonia induced by bleomycin administration.
Results: Higher levels of serum SP-D at the time of the initial visit to the Sapporo Medical University Hospital were associated with poorer prognoses, while SP-A showed no significant affect on survival. Causes of the elevation in sera were due to the acceleration of, not only production in the lungs, leakage into the circulation. The elevation was associated with alveolitis but not fibrosis.
Conclusions: SP-D is a good predictor of the prognosis in patients with IPF.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1440-1843.2006.00809.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!